RE:RE:Working Capital...On of my preferred take-aways from Q2s (yesterday's Agoracom interview) is that DM financials are now "squeeky clean" - meaning no remaining debt along with the, roughly, $10M cash on hand.
At that rate, if all goes well, I expect
Q3s will see an increase to the
cash on hand to $15Mish,
no debt and, hopefully,
increased AI income (perhaps not including the alluded to $40M contract, however, given that this would need to be announced before 30 Sept, if it were to be included).
MUTDMUTD wrote: ... and that is as of 30 June 2021... so not including any gains in the last 1.5 months nor for the remainder of the 12 month period referred to... likely not including the 20k test SCRN indicated in an NR... nor whatever percentage DM has of the long awaited, yet to be awarded, $40M AI cobid that Marshall is "very bullish" on until further updates are provided... nor revenue from MediCall which Marshall expects to generate almost upon introduction to clients.... nor additional Covid test sales that Marshall said DM is receiving inquiries about from more people/groups than ever now...that will all likely further extend the funded operations period IMO... All IMO. DYODD.